Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
Abstract Purpose An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2022-10-01
|
| Series: | Journal of Cancer Research and Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00432-022-04407-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832595041700282368 |
|---|---|
| author | Volker Arndt Daniela Doege Stefan Fröhling Peter Albers Hana Algül Ralf Bargou Carsten Bokemeyer Martin Bornhäuser Christian H. Brandts Peter Brossart Sara Yvonne Brucker Tim H. Brümmendorf Hartmut Döhner Norbert Gattermann Michael Hallek Volker Heinemann Ulrich Keilholz Thomas Kindler Cornelia von Levetzow Florian Lordick Ulf Peter Neumann Christoph Peters Dirk Schadendorf Stephan Stilgenbauer Thomas Zander Daniel Zips Delia Braun Thomas Seufferlein Gerd Nettekoven Michael Baumann |
| author_facet | Volker Arndt Daniela Doege Stefan Fröhling Peter Albers Hana Algül Ralf Bargou Carsten Bokemeyer Martin Bornhäuser Christian H. Brandts Peter Brossart Sara Yvonne Brucker Tim H. Brümmendorf Hartmut Döhner Norbert Gattermann Michael Hallek Volker Heinemann Ulrich Keilholz Thomas Kindler Cornelia von Levetzow Florian Lordick Ulf Peter Neumann Christoph Peters Dirk Schadendorf Stephan Stilgenbauer Thomas Zander Daniel Zips Delia Braun Thomas Seufferlein Gerd Nettekoven Michael Baumann |
| author_sort | Volker Arndt |
| collection | DOAJ |
| description | Abstract Purpose An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic. Methods Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022. Results The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care. Conclusions This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future. |
| format | Article |
| id | doaj-art-4ab718b28c7241eaa5a6b9e9c207ba81 |
| institution | Kabale University |
| issn | 0171-5216 1432-1335 |
| language | English |
| publishDate | 2022-10-01 |
| publisher | Springer |
| record_format | Article |
| series | Journal of Cancer Research and Clinical Oncology |
| spelling | doaj-art-4ab718b28c7241eaa5a6b9e9c207ba812025-01-19T12:08:55ZengSpringerJournal of Cancer Research and Clinical Oncology0171-52161432-13352022-10-01149291391910.1007/s00432-022-04407-1Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemicVolker Arndt0Daniela Doege1Stefan Fröhling2Peter Albers3Hana Algül4Ralf Bargou5Carsten Bokemeyer6Martin Bornhäuser7Christian H. Brandts8Peter Brossart9Sara Yvonne Brucker10Tim H. Brümmendorf11Hartmut Döhner12Norbert Gattermann13Michael Hallek14Volker Heinemann15Ulrich Keilholz16Thomas Kindler17Cornelia von Levetzow18Florian Lordick19Ulf Peter Neumann20Christoph Peters21Dirk Schadendorf22Stephan Stilgenbauer23Thomas Zander24Daniel Zips25Delia Braun26Thomas Seufferlein27Gerd Nettekoven28Michael Baumann29Division of Clinical Epidemiology and Aging Research (C070), Unit of Cancer Survivorship (C071), German Cancer Research Center (DKFZ)Division of Clinical Epidemiology and Aging Research (C070), Unit of Cancer Survivorship (C071), German Cancer Research Center (DKFZ)Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)Department of Urology, Comprehensive Cancer Center/Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), Medical Faculty of the Heinrich Heine University DüsseldorfComprehensive Cancer Center München, Institute for Tumor Metabolism, Klinikum rechts der Isar, Technical University of MunichComprehensive Cancer Center Mainfranken, University Hospital WürzburgMedical Clinic and Polyclinic II, Center for Oncology, University Cancer Center Hamburg, University Medical Center Hamburg-EppendorfMedical Clinic I, National Center for Tumor Diseases (NCT/UCC), University Hospital Carl Gustav Carus Dresden, TU DresdenUniversity Cancer Center (UCT) Frankfurt-Marburg, Frankfurt University HospitalMedical Clinic III and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital BonnComprehensive Cancer Center Tübingen-Stuttgart and Department of Women’s Health, University Hospital TübingenMedical Clinic IV and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital of RWTH AachenComprehensive Cancer Center Ulm (CCCU) and Department of Internal Medicine III, University Hospital UlmDepartment of Hematology, Oncology and Clinical Immunology, Comprehensive Cancer Center/Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), Medical Faculty of the Heinrich Heine University DüsseldorfClinic I for Internal Medicine and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital CologneMedical Clinic and Polyclinic III, LMU HospitalCharité Comprehensive Cancer Center (CCCC)University Cancer Center (UCT), University Medical Center MainzClinic I for Internal Medicine and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital CologneUniversity Cancer Center Leipzig and Department of Medicine II, University of Leipzig Medical CenterDepartment of Visceral and Transplantation Surgery, University Hospital of RWTH AachenTumor Center Freiburg, Institute of Molecular Medicine and Cell ResearchWest German Tumor Center (WTZ) Essen and Clinic for Dermatology, Essen University HospitalComprehensive Cancer Center Ulm (CCCU) and Department of Internal Medicine III, University Hospital UlmClinic I for Internal Medicine and Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital CologneComprehensive Cancer Center Tübingen-Stuttgart and Department of Radiation Oncology, University Hospital TübingenGerman Cancer Research Center (DKFZ)German Cancer SocietyGerman Cancer AidGerman Cancer Research Center (DKFZ)Abstract Purpose An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic. Methods Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022. Results The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care. Conclusions This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.https://doi.org/10.1007/s00432-022-04407-1SARS-CoV-2 infectionEarly diagnosis of cancerTreatment delaysAftercareComprehensive cancer centers |
| spellingShingle | Volker Arndt Daniela Doege Stefan Fröhling Peter Albers Hana Algül Ralf Bargou Carsten Bokemeyer Martin Bornhäuser Christian H. Brandts Peter Brossart Sara Yvonne Brucker Tim H. Brümmendorf Hartmut Döhner Norbert Gattermann Michael Hallek Volker Heinemann Ulrich Keilholz Thomas Kindler Cornelia von Levetzow Florian Lordick Ulf Peter Neumann Christoph Peters Dirk Schadendorf Stephan Stilgenbauer Thomas Zander Daniel Zips Delia Braun Thomas Seufferlein Gerd Nettekoven Michael Baumann Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic Journal of Cancer Research and Clinical Oncology SARS-CoV-2 infection Early diagnosis of cancer Treatment delays Aftercare Comprehensive cancer centers |
| title | Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic |
| title_full | Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic |
| title_fullStr | Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic |
| title_full_unstemmed | Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic |
| title_short | Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic |
| title_sort | cancer care in german centers of excellence during the first 2 years of the covid 19 pandemic |
| topic | SARS-CoV-2 infection Early diagnosis of cancer Treatment delays Aftercare Comprehensive cancer centers |
| url | https://doi.org/10.1007/s00432-022-04407-1 |
| work_keys_str_mv | AT volkerarndt cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT danieladoege cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT stefanfrohling cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT peteralbers cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT hanaalgul cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT ralfbargou cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT carstenbokemeyer cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT martinbornhauser cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT christianhbrandts cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT peterbrossart cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT sarayvonnebrucker cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT timhbrummendorf cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT hartmutdohner cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT norbertgattermann cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT michaelhallek cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT volkerheinemann cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT ulrichkeilholz cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT thomaskindler cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT corneliavonlevetzow cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT florianlordick cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT ulfpeterneumann cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT christophpeters cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT dirkschadendorf cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT stephanstilgenbauer cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT thomaszander cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT danielzips cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT deliabraun cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT thomasseufferlein cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT gerdnettekoven cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic AT michaelbaumann cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic |